| Fri, Nov 6, 2009 | | • | Oculus, Bianco and Cel-Sci Oh My!: BioBuzz
at TheStreet.com (Fri, Nov 6)
| | • | BioCryst Competition for IV Flu Drug: BioBuzz
at TheStreet.com (Fri, Nov 6)
| | • | New Drug for H1N1 Flu Offers Hope
at The New York Times (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Wall St storms ahead on productivity boost
at FT.com (Thu, Nov 5)
| | • | BioCryst Winners and Losers: BioBuzz
at TheStreet.com (Thu, Nov 5)
| | • | BioCryst ships 10K doses of flu drug to government
at bizjournals.com (Thu, Nov 5)
| | • | Cel-Sci's Lawyer Speaks: BioBuzz
at TheStreet.com (Thu, Nov 5)
| | • | U.S. buys $22.5M worth of BioCryst H1N1 flu vaccine
at bizjournals.com (Thu, Nov 5)
| | • | The $2000 Swine Flu Drug
Indie Research (Thu, Nov 5)
| | • | BioCryst receives $22.5 million peramivir order
AP (Thu, Nov 5)
| | • | BioCryst Ships Flu Drug to U.S. Government: BioBuzz
at TheStreet.com (Thu, Nov 5)
| | • | BioCryst Receives First Peramivir Order From U.S. Government
PR Newswire (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | BioCryst partner seeks peramivir approval in Japan
AP (Wed, Nov 4)
| | • | BioCryst partner files to market flu drug in Japan
at bizjournals.com (Wed, Nov 4)
| | • | BioCryst's Partner Shionogi Files for Peramivir Regulatory Approval in Japan
PR Newswire (Wed, Nov 4)
| | Mon, Nov 2, 2009 | | • | FDA Official Urges Caution on New H1N1 Drug
at CNBC (Mon, Nov 2)
| | • | UPDATE - More swine flu vaccine ready in US; kids need 2 doses
at Reuters (Mon, Nov 2)
| | • | Swine Flu Stock Picking Rewards Winners Handsomely
Indie Research (Mon, Nov 2)
| | Thu, Oct 29, 2009 | | • | BioCryst to Present at Oppenheimer Healthcare Conference
PR Newswire (Thu, Oct 29)
| | • | BioCryst loss widens, but H1N1 flu drug almost ready
at bizjournals.com (Thu, Oct 29)
|
Add BCRX News to My Yahoo!:
 
| |
|
2.03% Nasdaq 0.00%
Headlines
